Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-12-05 | 2020-01-30 | 100287 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-12-05 | 2020-01-30 | 100290 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-09 | 2020-03-26 | 102917 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-01-17 | 2020-01-25 | 103561 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-01-30 | 103566 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120238 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120241 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120244 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2023-04-28 | 120247 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2023-04-28 | 120250 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2022-03-26 | 120253 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120303 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120306 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120309 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120312 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120315 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120318 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-05-06 | 2021-06-03 | 138907 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-05-13 | 2022-03-18 | 139309 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2021-05-20 | 2021-06-24 | 139752 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |